Table 1.
Baseline characteristics.
| No. Patients (%) | ||
|---|---|---|
| Total no. patients | 41 (100) | |
| Age (at focal salvage HDR) a | 72 (67–76) | |
| iPSA before primary RT a,b | 12.4 (8.1–23.8) | |
| PSA before focal salvage HDR a,b | 4.6 (2.7–7.8) | |
| Primary prostate cancer treatment | EBRT | 21 (51.2) |
| I-125 LDR | 19 (46.3) | |
| Focal HDR-BT | 1 (2.4) | |
| Gleason score c primary tumor | 3 + 3 = 6 | 22 (53.7) |
| 3 + 4 = 7 | 11 (26.8) | |
| 4 + 3 = 7 | 5 (12.2) | |
| Sumscore 8 | 1 (2.4) | |
| Sumscore 9/10 | 2 (4.9) | |
| Time to salvage treatment (years) d | 7.70 ± 3.56 | |
a: Expressed as median with interquartile range. b: In ng/mL. c: Grouped according to AJCC grade group system. d: Expressed as mean ± standard deviation. HDR: high dose rate. iPSA: (initial) prostate specific antigen. RT: radiotherapy. EBRT: external beam radiotherapy. LDR: low dose rate. BT: brachytherapy.